UBS Group’s ARYA Sciences Acquisition Corp II Unit ARYBU Stock Holding History

UBS Group’s Portfolio ARYBU Stock Details ARYBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,559	Closed	-$17K	–	9151
2020 Q3	$17K	Buy	+1,559	New	+$17.7K	﹤0.01%	6460

UBS Group's ARYBU Position: Q4 2020 in Review

UBS Group sold out of ARYA Sciences Acquisition Corp II Unit (ARYBU) in Q4 2020, closing a stake of 1,559 shares — an estimated $17K sold.

UBS Group first reported a position in ARYBU in Q3 2020 and held it in 1 quarter. The position peaked at $17K in Q3 2020. 0 funds tracked by Wall St. Rank hold ARYBU as of Q4 2020.

UBS Group reported no remaining ARYA Sciences Acquisition Corp II Unit position as of Q4 2020 after selling out during the quarter.
UBS Group sold 1,559 ARYA Sciences Acquisition Corp II Unit shares in Q4 2020, an estimated $17K.
UBS Group first reported a position in ARYA Sciences Acquisition Corp II Unit in Q3 2020 and held it in 1 quarter.
UBS Group's ARYA Sciences Acquisition Corp II Unit position peaked at $17K in Q3 2020.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp II Unit as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.